The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Exploring the Relationship between Atrial Fibrillation, Hypertension, and Stroke
Subanalysis of a study comparing warfarin and apixaban in patients with atrial fibrillation found that uncontrolled hypertension increased the risk of stroke or systemic embolism in these patients.
New PCI Guidance Aims to Increase Safety, Maintain Quality
A new guidance document on percutaneous coronary intervention (PCI) cites the need for new safety and quality protocols to address the increasing number of PCIs performed at centers with no on-site cardiac surgery backup available.
LARIAT Technique for Atrial Fibrillation Reduces Stroke Risk
Minimally invasive surgical technique for patients with atrial fibrillation who cannot tolerate standard anticoagulant therapy uses sutures to tie off the left atrial appendage and offers increased stroke protection.
Study Examines Heart Failure Care Protocol
March 7th 2014Stressing the significant effect heart failure has on quality of life, a study published in Heart found that patients' and their families' lack of knowledge on their condition causes delays in seeking medical attention and an absence of a long-term care plan.
FDA Approves Ablation Catheter for Atrial Fibrillation
The US Food and Drug Administration (FDA) has approved a new ablation catheter billed by its maker as the first such device on the U.S. market "that enables direct and real-time measurement of contact force" during procedures.
New Cholesterol Treatment Guideline: A Q&A With Thomas Dayspring, MD, FACP, FNLA, NCMP
March 5th 2014Thomas Dayspring, MD, FACP, FNLA, NCMP, discusses the promises and pitfalls of the 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.